HMGB1 is a well-characterized DAMP in the setting of stroke, where its in vivo neutralization results in decreased microglial activation, cytokine and iNOS expressions, and reduced permeability of the blood brain barrier [67, 68]. Here, HMGB1 is linked to Stroke.